GB

Govinda Rao Bhisetti

VI Vertex Pharmaceuticals Incorporated: 27 patents #80 of 896Top 9%
📍 Lexington, MA: #179 of 2,299 inventorsTop 8%
🗺 Massachusetts: #3,693 of 88,656 inventorsTop 5%
Overall (All Time): #147,280 of 4,157,543Top 4%
27
Patents All Time

Issued Patents All Time

Showing 1–25 of 27 patents

Patent #TitleCo-InventorsDate
8765731 Benzimidazole analogues for the treatment or prevention of flavivirus infections James A. Henderson, John Patrick Maxwell, Louis Vaillancourt, Mark A. Morris, Ronald Grey, Jr. +16 more 2014-07-01
8759353 Co-crystals and pharmaceutical compositions comprising the same Patrick R. Connelly, Irina Nikolaevna Kadiyala, Kathy Stavropoulos, Yuegang Zhang, Steven C. Johnston +2 more 2014-06-24
8618152 Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases Luc Farmer, Robert B. Perni, Keith P. Wilson 2013-12-31
8354419 Benzimidazole analogues for the treatment or prevention of flavivirus infections James A. Henderson, John Patrick Maxwell, Louis Vaillancourt, Mark A. Morris, Ronald Grey, Jr. +16 more 2013-01-15
8314141 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease Roger D. Tung, Scott L. Harbeson, David Deininger, Mark A. Murcko, Luc Farmer 2012-11-20
7919520 Inhibitors of tace Upul K. Bandarage, Jon Come, Emanuele Perola, Jeffrey O. Saunders, Shi-Kai Tian +1 more 2011-04-05
7608632 Sulfonamide inhibitors of aspartyl protease Roger D. Tung, Mark A. Murcko 2009-10-27
7494988 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease Robert B. Perni, John J. Court, Ethan O'Malley 2009-02-24
7485664 Inhibitors of TACE Upul K. Bandarage, Jon Come, Emanuele Perola, Jeffrey O. Saunders, Tiansheng Wang +1 more 2009-02-03
7388017 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease Roger D. Tung, Scott L. Harbeson, David Deininger, Mark A. Murcko, Luc Farmer 2008-06-17
7321063 Sulfonamide inhibitors of aspartyl protease Roger D. Tung, Mark A. Murcko 2008-01-22
6720335 Sulfonamide inhibitors of aspartyl protease Roger D. Tung, Mark A. Murcko 2004-04-13
6617309 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease Roger D. Tung, Scott L. Harbeson, David Deininger, Mark A. Murcko, Luc Farmer 2003-09-09
6608067 Inhibitors of serine proteases, particularly HCV NS3 protease Roger D. Tung, Luc Farmer 2003-08-19
6392046 Sulfonamide inhibitors of aspartyl protease Roger D. Tung, Mark A. Murcko 2002-05-21
6372778 Sulfonamide inhibitors of aspartyl protease Roger D. Tung, Mark A. Murcko 2002-04-16
6265380 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease Roger D. Tung, Scott L. Harbeson, David Deininger, Mark A. Murcko, Luc Farmer 2001-07-24
6127372 Sulfonamide inhibitors of aspartyl protease Roger D. Tung, Francesco G. Salituro, David Deininger, Mark A. Murcko, Perry M. Novak 2000-10-03
6004957 Sulfonamide inhibitors of aspartyl protease Roger D. Tung, Mark A. Murcko 1999-12-21
5990155 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease Roger D. Tung 1999-11-23
5977137 Sulfonamide inhibitors of aspartyl protease Roger D. Tung, Mark A. Murcko 1999-11-02
5945413 Aspartyl protease inhibitors Roger D. Tung, Francesco G. Salituro, David Deininger, Christopher Baker, Andrew Spaltenstein 1999-08-31
5883252 Aspartyl protease inhibitors Roger D. Tung, Francesco G. Salituro, David Deininger, Christopher Baker 1999-03-16
5856353 Sulfonamide inhibitors of aspartyl protease Roger D. Tung, Mark A. Murcko 1999-01-05
5783701 Sulfonamide inhibitors of aspartyl protease Roger D. Tung, Mark A. Murcko 1998-07-21